首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5456篇
  免费   3篇
  国内免费   1篇
电工技术   1篇
综合类   2篇
化学工业   16篇
机械仪表   1篇
建筑科学   3篇
轻工业   8篇
水利工程   2篇
无线电   7篇
一般工业技术   11篇
冶金工业   5393篇
原子能技术   1篇
自动化技术   15篇
  2017年   1篇
  2016年   1篇
  2013年   4篇
  2012年   2篇
  2011年   4篇
  2010年   1篇
  2009年   1篇
  2008年   1篇
  2007年   5篇
  2006年   7篇
  2005年   4篇
  2004年   4篇
  2003年   3篇
  2002年   1篇
  2001年   1篇
  2000年   5篇
  1999年   166篇
  1998年   1673篇
  1997年   921篇
  1996年   584篇
  1995年   334篇
  1994年   293篇
  1993年   313篇
  1992年   40篇
  1991年   62篇
  1990年   70篇
  1989年   61篇
  1988年   68篇
  1987年   69篇
  1986年   54篇
  1985年   62篇
  1984年   1篇
  1983年   10篇
  1982年   28篇
  1981年   27篇
  1980年   53篇
  1979年   4篇
  1978年   13篇
  1977年   156篇
  1976年   340篇
  1975年   3篇
  1973年   2篇
  1972年   3篇
  1969年   1篇
  1955年   4篇
排序方式: 共有5460条查询结果,搜索用时 15 毫秒
51.
52.
53.
The CTFA Evaluation of Alternatives Program is an evaluation of the relationship between data from the Draize primary eye irritation test and comparable data from a selection of promising in vitro eye irritation tests. In Phase III, data from the Draize test and 41 in vitro endpoints on 25 representative surfactant-based personal care formulations were compared. As in Phase I and Phase II, regression modelling of the relationship between maximum average Draize score (MAS) and in vitro endpoint was the primary approach adopted for evaluating in vitro assay performance. The degree of confidence in prediction of MAS for a given in vitro endpoint is quantified in terms of the relative widths of prediction intervals constructed about the fitted regression curve. Prediction intervals reflect not only the error attributed to the model but also the material-specific components of variation in both the Draize and the in vitro assays. Among the in vitro assays selected for regression modeling in Phase III, the relationship between MAS and in vitro score was relatively well defined. The prediction bounds on MAS were most narrow for materials at the lower or upper end of the effective irritation range (MAS = 0-45), where variability in MAS was smallest. This, the confidence with which the MAS of surfactant-based formulations is predicted is greatest when MAS approaches zero or when MAS approaches 45 (no comment is made on prediction of MAS > 45 since extrapolation beyond the range of observed data is not possible). No single in vitro endpoint was found to exhibit relative superiority with regard to prediction of MAS. Variability associated with Draize test outcome (e.g. in MAS values) must be considered in any future comparisons of in vivo and in vitro test results if the purpose is to predict in vivo response using in vitro data.  相似文献   
54.
55.
56.
57.
58.
59.
烟气是火灾过程的重要物理现象 .烟气中悬浮的烟气颗粒目、尺寸分布、团聚效应和烟气的湍流效应是火灾探测的重要影响因素 .本文分析了火灾烟气的特征 ,为多参数特征的火灾探测提供了理论依据  相似文献   
60.
One hundred seven adult patients with thalassemia aged from 17 through 35 years and transplanted from HLA-identical siblings between November 1988 and September 1996 were evaluated on December 31, 1997. The outcome experience of 20 consecutive patients transplanted between November 13, 1988 and January 10, 1991 and reported in September 1992 is updated after 5 additional years. The experience on 87 patients transplanted between May 1991 and September 1996 is described and evaluated as of the end of December 1997. Of 107 patients, 69 survive between 1.5 and 9 years after transplantation. Sixty-six of these patients do not have thalassemia and are identified as ex-thalassemic after bone marrow transplantation. The youngest survivor is 20 years old, 6 are older than 30 years, and the oldest is 37 years of age. Patients with chronic active hepatitis at the time of transplant were significantly more likely to die than patients without (P =.05; relative risk, 2.05). Marrow transplantation is a valid treatment option for older patients with thalassemia who have suitable donors and show deterioration with conventional therapy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号